TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||
April 2014 Volume 10 Number 4 | |||||||||||||||||||||||||||||||||||||
In this issue Research Highlights News and Views Reviews Perspectives
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
NEWS AND VIEWS | Top | ||||||||||||||||||||||||||||||||||||
Genetics: A new interpretation of genetic studies in RA Michel Neidhart & Emmanuel Karouzakis Published online: 25 February 2014 p199 | doi:10.1038/nrrheum.2014.21 Understanding the genetics of rheumatoid arthritis (RA) is complex, multiple genes and environmental factors are involved. A new multicentre genetic study summarizes the fundamental gene polymorphisms, pathways and cell types that are related to RA and, based on this analysis, proposes new targets for RA drug treatments. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Connective tissue diseases: Systemic sclerosis: beyond limited and diffuse subsets? John Varga & Monique Hinchcliff Published online: 18 February 2014 p200 | doi:10.1038/nrrheum.2014.22 Patients with systemic sclerosis present with varying clinical features, have different responses to therapy, and end up with different outcomes. Categorizing patients improves disease management. A new study now proposes that patients with systemic sclerosis and overlapping features of another connective tissue disease might form a distinct disease subset. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Rheumatoid arthritis: Treating cardiovascular risk in RA requires multidisciplinary care Rekha Mankad & Sherine E. Gabriel Published online: 18 March 2014 p202 | doi:10.1038/nrrheum.2014.37 Rheumatoid arthritis is associated with an excess risk of cardiovascular disease, but current cardiovascular risk models might not be adequate to fully predict individual risk in a patient with this disease. Does the solution lie in closer collaboration between rheumatologists and cardiologists? Full Text | PDF | |||||||||||||||||||||||||||||||||||||
REVIEWS | Top | ||||||||||||||||||||||||||||||||||||
Neural mechanisms underlying the pain of juvenile idiopathic arthritis Luke La Hausse de Lalouvière, Yiannis Ioannou & Maria Fitzgerald Published online: 04 February 2014 p205 | doi:10.1038/nrrheum.2014.4 Pain is a debilitating symptom of juvenile idiopathic arthritis (JIA) that can persist despite effective disease control. Insights into the underlying mechanisms of pain in JIA could highlight new treatment approaches and improve management. Here, the neurobiological basis of pain in JIA is described, using findings from animal models to inform the situation in humans. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE Kevin D. Deane & Hani El-Gabalawy Published online: 11 February 2014 p212 | doi:10.1038/nrrheum.2014.6 That many autoimmune rheumatic diseases have an extended preclinical period, during which autoimmunity develops and evolves, is becoming apparent. In this Review, the authors discuss the current knowledge of the preclinical pathogenesis of rheumatoid arthritis and systemic lupus erythematosus, and use these diseases as models to highlight how such understanding could, in the future, improve therapeutic intervention and even lead to preventative approaches in autoimmune rheumatic diseases. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||
Persisting eicosanoid pathways in rheumatic diseases Marina Korotkova & Per-Johan Jakobsson Published online: 11 February 2014 p229 | doi:10.1038/nrrheum.2014.1 Eicosanoids are major regulators of inflammation and are thought to be involved in the pathogenesis of rheumatic diseases. Here, the authors provide an overview of eicosanoid pathways in a variety of rheumatic diseases (including rheumatoid arthritis, osteoarthritis and gout, among others) and describe how targeting this pathway might lead to novel anti-inflammatory treatment strategies. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||
Hand osteoarthritis—nonpharmacological and pharmacological treatments Margreet Kloppenburg Published online: 28 January 2014 p242 | doi:10.1038/nrrheum.2013.214 Hand osteoarthritis (OA) is a common disease and the prevalence is expected to increase further with ageing of the general population. In this comprehensive Review, Margreet Kloppenburg describes the nonpharmacological and pharmacological management strategies currently available to alleviate the symptoms of hand OA. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
PERSPECTIVES | Top | ||||||||||||||||||||||||||||||||||||
OPINION Multimorbidity and rheumatic conditions—enhancing the concept of comorbidity Helga Radner, Kazuki Yoshida, Josef S. Smolen & Daniel H. Solomon Published online: 14 January 2014 p252 | doi:10.1038/nrrheum.2013.212 The concepts of comorbidity and multimorbidity consider a patient with multiple diseases from different perspectives, which affects how a clinician approaches treatment. In this Perspectives article, Radner and colleagues discuss the concept of multimorbidity and how its integration into daily clinical practice can improve the care of patients with rheumatic conditions. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
|
*Journal Citation Reports, Thomson, 2012. Nature Reviews Rheumatology was previously published as Nature Clinical Practice Rheumatology. |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
No comments:
Post a Comment
Keep a civil tongue.